Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
iShares Future Exponential Technologies ETF
XT
$3.93B
| $3.11M | ﹤0.01% |
52,100
+42,000
| +416% | +$2.55M |
|
1752
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.4B
| $3.11M | ﹤0.01% |
+64,300
| New | +$3.22M |
|
1753
McGrath RentCorp
MGRC
$2.94B
| $3.1M | ﹤0.01% |
+27,682
| New | +$3.18M |
|
1754
SelectQuote
SLQT
$131M
| $3.09M | ﹤0.01% |
831,500
-244,900
| -23% | -$625K |
|
|
DAWN
1755
DELISTED
Day One Biopharmaceuticals
DAWN
| $3.09M | ﹤0.01% |
243,740
+148,900
| +157% | +$2.07M |
|
1756
Arcos Dorados Holdings
ARCO
$1.76B
| $3.08M | ﹤0.01% |
422,934
+372,000
| +730% | +$3.19M |
|
1757
Telos
TLS
$365M
| $3.07M | ﹤0.01% |
898,872
-297,128
| -25% | -$1.06M |
|
1758
Nexa Resources
NEXA
$1.79B
| $3.07M | ﹤0.01% |
349,200
-4,000
| -1% | -$31.4K |
|
1759
JPMorgan Active Growth ETF
JGRO
$10B
| $3.07M | ﹤0.01% |
37,900
+32,800
| +643% | +$2.64M |
|
1760
Valhi
VHI
$388M
| $3.07M | ﹤0.01% |
131,217
+1,800
| +1% | +$53.5K |
|
1761
International Money Express
IMXI
$370M
| $3.07M | ﹤0.01% |
147,300
+29,900
| +25% | +$587K |
|
1762
Marchex
MCHX
$83.3M
| $3.07M | ﹤0.01% |
1,752,364
-24,700
| -1% | -$45.6K |
|
1763
Sasol
SSL
$7.14B
| $3.06M | ﹤0.01% |
670,011
+364,111
| +119% | +$2.06M |
|
1764
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
| $3.04M | ﹤0.01% |
+10,500
| New | +$3.06M |
|
1765
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.63B
| $3.04M | ﹤0.01% |
73,500
-28,200
| -28% | -$1.18M |
|
|
ACB
1766
Aurora Cannabis
ACB
$174M
| $3.04M | ﹤0.01% |
714,655
+56,400
| +9% | +$277K |
|
1767
Molson Coors Class B
TAP
$7.93B
| $3.03M | ﹤0.01% |
52,800
-26,300
| -33% | -$1.53M |
|
1768
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
| $3.02M | ﹤0.01% |
125,900
+55,600
| +79% | +$1.34M |
|
1769
Capital Group Growth ETF
CGGR
$25.1B
| $3.01M | ﹤0.01% |
81,000
+55,000
| +212% | +$2.02M |
|
1770
MasterCraft Boat Holdings
MCFT
$608M
| $3.01M | ﹤0.01% |
157,756
-30,844
| -16% | -$590K |
|
|
PWOD
1771
DELISTED
Penns Woods Bancorp
PWOD
| $3M | ﹤0.01% |
98,819
-14,150
| -13% | -$407K |
|
1772
Cytek Biosciences
CTKB
$553M
| $3M | ﹤0.01% |
462,600
+251,000
| +119% | +$1.5M |
|
1773
First Bancorp
FNLC
$402M
| $3M | ﹤0.01% |
109,663
-4,000
| -4% | -$110K |
|
1774
iShares MSCI India Small-Cap ETF
SMIN
$776M
| $3M | ﹤0.01% |
39,200
-22,900
| -37% | -$1.88M |
|
1775
Pembina Pipeline
PBA
$28.1B
| $3M | ﹤0.01% |
+81,063
| New | +$3.3M |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.